WallStreetZenWallStreetZen

NASDAQ: INM
Inmed Pharmaceuticals Inc Stock Ownership - Who owns Inmed Pharmaceuticals?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Inmed Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alexandra Diane Janet ManciniInsider2024-07-31240$0.18
$42.24Sell

1 of 1

INM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INM insiders and whales buy or sell their stock.

INM Shareholders

What type of owners hold Inmed Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shane Aaron Johnson48.30%583,023$1.72MInsider
Eric A. Adams3.64%43,959$129.55kInsider
Advisorshares Investments LLC3.19%38,460$113.34kInstitution
Andrew Hull3.17%38,258$112.75kInsider
Bruce Colwill0.95%11,515$33.93kInsider
Ubs Group Ag0.86%10,408$30.67kInstitution
Osaic Holdings Inc0.00%27$79.57Institution
Federation Des Caisses Desjardins Du Quebec0.00%1$2.95Institution
Allsquare Wealth Management LLC0.00%1$2.95Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 2

INM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INM4.05%56.06%Net Selling
MBIO86.72%13.28%Net SellingNet Selling
CELZ1.71%2.02%Net SellingNet Selling
XRTX8.24%0.00%
THAR3.64%96.36%Net Buying
View Top Biotech Stocks

Inmed Pharmaceuticals Stock Ownership FAQ

Who owns Inmed Pharmaceuticals?

Inmed Pharmaceuticals (NASDAQ: INM) is owned by 4.05% institutional shareholders, 56.06% Inmed Pharmaceuticals insiders, and 39.89% retail investors. Shane Aaron Johnson is the largest individual Inmed Pharmaceuticals shareholder, owning 583,023.00 shares representing 48.30% of the company. Shane Aaron Johnson's Inmed Pharmaceuticals shares are currently valued at $1.73M.

If you're new to stock investing, here's how to buy Inmed Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.